New guidelines on marginal zone lymphoma
Published on: 4 March 2020New European guidelines give evidence-based recommendations for the diagnosis, treatment and follow-up of people with marginal zone lymphoma.
New guidelines have just been published by the European Society for Medical Oncology (ESMO) covering recommendations for the diagnosis, staging, treatment and follow-up of people with:
• nodal marginal zone lymphoma
• extranodal marginal zone lymphoma (also known as MALT lymphoma)
• splenic marginal zone lymphoma.
The guidelines aim to make sure people with marginal zone lymphoma receive the best available care based on up-to-date evidence from clinical trials.
For more information about clinical trials for lymphoma, visit Lymphoma TrialsLink.
4 March 2020